Texas Christian University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Texas Christian University sits in the top decile of US sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count).
Texas Christian University: 26 sponsored US clinical trials, 6 recruiting.
Texas Christian University sponsors 26 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 16 completed. 1 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Probiotics, with 1 trials.
Top-decile sponsor footprint
Texas Christian University ranks in the top decile of sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
26 total, page 1 of 1
Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
NCT07688720
Alii Supplement Study
NCT07271316
Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer
NCT07377331
Impact of Prebiotic Sodas on Satiety and Metabolic Responses in Healthy Men
NCT07105826
Translaryngeal Vibration for Hyperfunctional Voice Disorders
NCT07145086
Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center
NCT04276792
Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders
NCT07180446
The TCU Division I Collegiate Athlete Study
NCT07006051
Justice Community Overdose Innovation Network II TCU Hub
NCT07528846
Project CARE-D - Online Caregiver Education for Dementia
NCT07377318
Effect of Supplement on Appetite and GLP-1
NCT06790771
Learn About Caring for a Person Living With Dementia
NCT07381010
Family Assessment Motivation, and Linkage Intervention (FAMLI)
NCT04604236
The Substance Use and Health Risk Intervention (SUHRI) for Justice-involved Youth
NCT06132282
Telehealth-Clinical Advocacy Project
NCT04911426
Preventing Opioid Use Among Justice-involved Youth as They Transition to Adulthood Leveraging Safe Adults (LeSA)
NCT04678960
The Effect of Diet Composition on Performance, Expenditure, Blood Lipids, and Appetite Hormones in Highly Trained Cyclists
NCT04097171
The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players
NCT03582267
Effects of a Weight Loss Intervention in College-age Women
NCT02966431
The Effect of an Acute Bout of Exercise on High-sugar Meal Induced Endothelial Dysfunction
NCT02919488
The Effect of Meal Composition on Blood Lipids
NCT02529709
Sustainable HIV Risk Reduction Strategies for Probationers
NCT02777086
The Effects of Probiotic Supplementation on Markers of Muscle Damage and Performance Following Exercise Induced Muscle Damage
NCT02520583
The Effect of Menu Labels on Calories Ordered in Hispanics
NCT02804503
The Effect of Changing the Eating Speed on Energy Intake
NCT01684553
Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Population
NCT00933153
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Therapeutic Areas
What is open in the Texas Christian University pipeline
6 recruiting of 26 indexed (23% open); 16 completed (62%).
Phase mix: 1 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Probiotics (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Texas Christian University: open-pipeline peers nationwide
Peers matched on 26 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Texas Christian University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 26 trials (± recruiting share)
- Abbott Diabetes Care · 26 trials · 12% recruiting
- Aldeyra Therapeutics · 26 trials · 4% recruiting
- California Polytechnic State University-San Luis Obispo · 26 trials · 19% recruiting
- DexCom · 26 trials · 4% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Texas Christian University page
26 registered trials is a research-attention snapshot, not an endorsement of Texas Christian University or any single study.
- 6 of Texas Christian University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Probiotics is the condition Texas Christian University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Probiotics trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Texas Christian University pipeline card: 26 registered trials from official public datasets.Report a data error.